Correlation Between Aadi Bioscience and Anebulo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Aadi Bioscience and Anebulo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aadi Bioscience and Anebulo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aadi Bioscience and Anebulo Pharmaceuticals, you can compare the effects of market volatilities on Aadi Bioscience and Anebulo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aadi Bioscience with a short position of Anebulo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aadi Bioscience and Anebulo Pharmaceuticals.
Diversification Opportunities for Aadi Bioscience and Anebulo Pharmaceuticals
-0.01 | Correlation Coefficient |
Good diversification
The 3 months correlation between Aadi and Anebulo is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Aadi Bioscience and Anebulo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anebulo Pharmaceuticals and Aadi Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aadi Bioscience are associated (or correlated) with Anebulo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anebulo Pharmaceuticals has no effect on the direction of Aadi Bioscience i.e., Aadi Bioscience and Anebulo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Aadi Bioscience and Anebulo Pharmaceuticals
Given the investment horizon of 90 days Aadi Bioscience is expected to under-perform the Anebulo Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Aadi Bioscience is 1.52 times less risky than Anebulo Pharmaceuticals. The stock trades about -0.13 of its potential returns per unit of risk. The Anebulo Pharmaceuticals is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 164.00 in Anebulo Pharmaceuticals on December 28, 2024 and sell it today you would lose (28.00) from holding Anebulo Pharmaceuticals or give up 17.07% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 88.52% |
Values | Daily Returns |
Aadi Bioscience vs. Anebulo Pharmaceuticals
Performance |
Timeline |
Aadi Bioscience |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Anebulo Pharmaceuticals |
Aadi Bioscience and Anebulo Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Aadi Bioscience and Anebulo Pharmaceuticals
The main advantage of trading using opposite Aadi Bioscience and Anebulo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aadi Bioscience position performs unexpectedly, Anebulo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anebulo Pharmaceuticals will offset losses from the drop in Anebulo Pharmaceuticals' long position.Aadi Bioscience vs. Anebulo Pharmaceuticals | Aadi Bioscience vs. Adagene | Aadi Bioscience vs. Acrivon Therapeutics, Common | Aadi Bioscience vs. AnaptysBio |
Anebulo Pharmaceuticals vs. Adagene | Anebulo Pharmaceuticals vs. Acrivon Therapeutics, Common | Anebulo Pharmaceuticals vs. AnaptysBio | Anebulo Pharmaceuticals vs. Mineralys Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |